In the filing, Dr. Wiesel reportedly said his patented invention took “pioneering steps” in creating a system for atrial fibrillation detection based on monitoring “irregular pulse rhythms from a success of time intervals.” He filed the lawsuit to receive royalties from Apple for its use of the alleged copycat technology and to prevent Apple from using the technology without his permission.
Dr. Wiesel claimed in the lawsuit that he first provided Apple with detailed information about his patent in September 2017, Bloomberg reports, but that the company has “refused to negotiate in good faith to avoid this lawsuit.”
Apple did not respond to Bloomberg‘s request for comment.
More articles on health IT:
36 hospitals, health systems that partnered with big tech in 2019
Tech-based population health strategy reduces readmissions, shortens stays
AHA critiques FDA’s expanded regulation of clinical decision support software
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
